Mortality

Evidence from multiple trials suggests that higher dose corticosteroids “probably” lessen the mortality risk among patients with severe to critical COVID-19, according to study results published in Annals of the American Thoracic Society.

Social isolation and loneliness were linked to an increased risk for all-cause and cause-specific types of mortality, according to a recent systematic review and meta-analysis published in Nature Human Behavior.

Transgender individuals may be at significantly higher risk for suicide compared the nontransgender population, according to a study published in JAMA.

A post-hospitalization home-delivered meal program was linked to lower 30-day mortality and rehospitalization, according to the results of research published in JAMA Health Forum.

Results from a study completed in eight European countries showed that patients receiving high-dose hemodiafiltration had lower mortality vs. patients using high-flux dialysis.

Patients who contract COVID-19 after total joint arthroplasty may be at increased risk for complications, including death, according to published results.

Prolonged prone position ventilation for 24 hours or more was linked to less death at 30 and 90 days in COVID-19 patients on mechanical ventilation, according to study results published in CHEST.

A 0.5 mg dose of colchicine, a drug commonly used for conditions such as gout, was recently approved by the FDA to prevent cardiovascular events in patients with residual inflammatory risk.

WASHINGTON — In patients with idiopathic pulmonary fibrosis, yearly lung function decline rates did not improve with two different dosages of ziritaxestat, according to an American Thoracic Society International Conference presentation.

Investigators of this study found similar 90-day mortality rates for patients who underwent total joint arthroplasty with either aspirin or enoxaparin for venous thromboembolism prophylaxis.